American employers of 100 or more employees may have until Jan. 4 to ensure all of their workers are either fully vaccinated or submit to weekly testing, according to an Emergency Temporary Standard (ETS) released on Nov. 4 by the Occupational Safety and Health Administration (OSHA). The rule was temporarily frozen by a federal appeals court in Louisiana on Nov. 6.

If it stands, however, OSHA’s rule will affect 84 million private sector workers across the country, according to the U.S. Department of Labor, including 31 million who were believed to be unvaccinated. Under the rule, U.S. corporations would need to require testing of unvaccinated employees to be compliant with the regulations for both workers exempt from vaccinations and for those companies without vaccine mandates.1 OSHA estimates that the ETS will require an additional 6.3 million tests per week in order for businesses to achieve compliance.

“American businesses have an incredible need right now for end-to-end managed testing programs that provide the testing, reporting, and compliance capabilities required by the new OSHA regulations,” says Erica Prowisor, executive vice president of GENETWORx, a fully integrated CAP-accredited laboratory. “Since the early days of the pandemic, we have been providing these kinds of specialized testing and compliance programs to a wide variety of industries and companies, including Fortune 500 companies, government entities, universities and colleges, and health providers.”

GENETWORx offers two types of onsite testing options for corporations. The first is a self-service model where GENETWORx helps businesses set up their own collection site with best practice recommendations and a testing package, including testing kits, shipping and return labels, FedEx boxes, personal protection equipment (PPE), and access to results reporting and compliance tools. 

The second is a full-service model in which GENETWORx provides end-to-end services from collection to results. This includes setting up the collection site, managing staffing for collection and registration, and providing all necessary equipment, supplies, and PPE, as well as access to all reporting and compliance tools. 

Additionally, organizations in New York City or Philadelphia can use Test Now and Go public COVID-19 test collection sites, where businesses can arrange a block of scheduled tests for their workers.

GENETWORx invested in infrastructure in the early part of the pandemic and has performed more than 7 million COVID-19 tests. The laboratory delivers COVID-19 test results within 24 to 48 hours that are 99% accurate and offer a reduced risk of false negatives. GENETWORx also offers antigen and rapid molecular point-of-care tests that can deliver results in less than 30 minutes. 

In partnership with Nucleus Healthcare, the laboratory also developed an app that ties together all aspects of the testing program in a comprehensive digital management system. The app was built on a software platform called Aura, which provides results record-keeping and reporting that can be used for managing state and federal compliance requirements as well as for allowing patients or providers to access test results from an online portal. The Aura testing platform has been used by numerous corporations, state and local governmental organizations, colleges, assisted living facilities, and other businesses over the past 20 months.

For more information, visit GENETWORx.

Featured Image: The GENETWORx corporate testing program offers two types of onsite options for U.S. businesses that will require unvaccinated workers to submit to weekly testing for the COVID-19 virus. Photo: GENETWORx.